These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1294943

  • 41. Recent strategies to overcome the hyperacute rejection in pig to human xenotransplantation.
    Igaz P.
    Yale J Biol Med; 2001; 74(5):329-40. PubMed ID: 11769339
    [Abstract] [Full Text] [Related]

  • 42. Xenotransplantation of discordant, immediately-vascularized organs.
    Bach FH.
    Clin Transplant; 1993 Feb; 7(1 part 2):90-2. PubMed ID: 10148368
    [No Abstract] [Full Text] [Related]

  • 43. Beyond hyperacute rejection: strategies for development of pig-->primate xenotransplantation.
    Hancock WW.
    Kidney Int Suppl; 1997 Mar; 58():S36-40. PubMed ID: 9067940
    [Abstract] [Full Text] [Related]

  • 44. Dominant role of complement in the hyperacute xenograft rejection reaction.
    Schilling A, Land W, Pratschke E, Pielsticker K, Brendel W.
    Surg Gynecol Obstet; 1976 Jan; 142(1):29-32. PubMed ID: 1105839
    [Abstract] [Full Text] [Related]

  • 45. Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium.
    Rieben R, Seebach JD.
    Trends Immunol; 2005 Jan; 26(1):2-5. PubMed ID: 15629401
    [Abstract] [Full Text] [Related]

  • 46. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model.
    Xu H, Gundry SR, Hancock WW, Matsumiya G, Zuppan CW, Morimoto T, Slater J, Bailey LL.
    J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1342-9. PubMed ID: 9628677
    [Abstract] [Full Text] [Related]

  • 47. The immunological barriers to xenotransplantation.
    Platt JL.
    Crit Rev Immunol; 1996 Jun; 16(4):331-58. PubMed ID: 8954254
    [Abstract] [Full Text] [Related]

  • 48. Xenotransplantation.
    Lu CY, Khair-el-Din TA, Dawidson IA, Butler TM, Brasky KM, Vazquez MA, Sicher SC.
    FASEB J; 1994 Nov; 8(14):1122-30. PubMed ID: 7958617
    [Abstract] [Full Text] [Related]

  • 49. Xenotransplantation.
    White SA, Nicholson ML.
    Br J Surg; 1999 Dec; 86(12):1499-514. PubMed ID: 10594496
    [Abstract] [Full Text] [Related]

  • 50. Future directions in transplantation: xenotransplantation.
    Somerville CA, d'Apice AJ.
    Kidney Int Suppl; 1993 Jul; 42():S112-21. PubMed ID: 8361121
    [Abstract] [Full Text] [Related]

  • 51. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
    Chen D, Cao R, Guo H, Chen G, Wang X, Shen S, Chen S.
    Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
    [Abstract] [Full Text] [Related]

  • 52. [Complement in organ xenotransplantation].
    Dalmasso AP.
    Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
    [No Abstract] [Full Text] [Related]

  • 53. Rejection of pig liver xenografts in patients with liver failure: implications for xenotransplantation.
    Tector AJ, Berho M, Fridell JA, DiCarlo A, Liu S, Soderland C, Barkun JS, Metrakos P, Tchervenkov JI.
    Liver Transpl; 2001 Feb; 7(2):82-9. PubMed ID: 11172389
    [Abstract] [Full Text] [Related]

  • 54. Complement regulation in the GalT KO era.
    Miyagawa S, Yamamoto A, Matsunami K, Wang D, Takama Y, Ueno T, Okabe M, Nagashima H, Fukuzawa M.
    Xenotransplantation; 2010 Feb; 17(1):11-25. PubMed ID: 20149185
    [Abstract] [Full Text] [Related]

  • 55. Transgenic pigs designed to express human α-galactosidase to avoid humoral xenograft rejection.
    Zeyland J, Gawrońska B, Juzwa W, Jura J, Nowak A, Słomski R, Smorąg Z, Szalata M, Woźniak A, Lipiński D.
    J Appl Genet; 2013 Aug; 54(3):293-303. PubMed ID: 23780397
    [Abstract] [Full Text] [Related]

  • 56. The prospects for xenotransplantation of the kidney.
    Platt JL.
    Curr Opin Nephrol Hypertens; 1997 May; 6(3):284-91. PubMed ID: 9263672
    [Abstract] [Full Text] [Related]

  • 57. Perspectives on complement in xenotransplantation.
    Mollnes TE, Fiane AE.
    Mol Immunol; 2003 Sep; 40(2-4):135-43. PubMed ID: 12914819
    [Abstract] [Full Text] [Related]

  • 58. [Pharmacological modulation of the complement system: an opportunity for successful xenotransplantation].
    Heckl-Ostreicher B, Kirschfink M.
    Immun Infekt; 1995 Apr; 23(2):53-4. PubMed ID: 7538095
    [Abstract] [Full Text] [Related]

  • 59. Protection of transplants against antibody-mediated injuries: from xenotransplantation to allogeneic transplantation, mechanisms and therapeutic insights.
    Kervella D, Le Bas-Bernardet S, Bruneau S, Blancho G.
    Front Immunol; 2022 Apr; 13():932242. PubMed ID: 35990687
    [Abstract] [Full Text] [Related]

  • 60. Xenotransplantation: how to overcome the complement obstacle?
    Mollnes TE, Fiane AE.
    Mol Immunol; 1999 Apr; 36(4-5):269-76. PubMed ID: 10403480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.